FDA Device recall Z-1773-2019
CardioCommand, Inc
- FDA Device
- Class III
- terminated
- Published 2019-06-19
On 2019-06-19 the FDA classified a Class III recall of CardioCommand, Inc by Cardiocommand, citing possible corrosion of the battery contact(s).
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1773-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-05-10 |
| Published | 2019-06-19 |
| Last updated | 2026-09-13 11:55 UTC |
| Company | Cardiocommand |
| Distribution | US |
Product
CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia
Reason
Possible corrosion of the battery contact(s).
Identifiers
| code_info | Serial Numbers: 8059, 8060, 8022, 8063, 8211 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1773-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.